Intectica is a Patent and Research group of companies with two headquarters: in Sofia (BG) – for our international clients, and Kyiv (UA) – for our former USSR clients. We provide wide range of IP and R&D services – from creation of the patent and TM strategy for safe entry to the market, to obtaining worldwide patent protection and monopoly for new products, using all IP law objects (TM, Patent, Design, copyright) and regional law features.

Over the course of long-term work in the patent field, we have developed own author’s algorithms and solutions for our main area of activity – the pharmaceutical market. For example, one of the most important pharma problems is ensuring new generic product has a safe entry to the market. In order to maintain support of the client’s interests in this task, we develop an individual work strategy and calculate possible risks. Conducting and analysis of results for FTO and patentability searches allow us to predict and avoid possible conflicts with competitors, and to create unique strategy for obtaining own protection and monopoly for our client.

During our practice we have gathered high qualified scientists-chemists, pharmacists and patent attorneys in our own Research department. In this way we can provide effective technical and patent support for manufacturers of pharmaceutical, chemical and cosmetic industry.

For our clients, we solve a variety of problems in the field of patenting pharmaceutical products:

 – dossier purchasing consulting with IP law support (name and product regional validity check)

 – risk calculation for generic or hybrid products

 – preparation new generic to regional entry

 – all kinds of patent searches (FTO, Patentability, etc)

 – development and implementation of a patent strategy

 – drafting and filing applications all over the world

Our Ukrainian headquarter covers Russia, Ukraine, Belarus, Uzbekistan, Moldova, Kyrzystan, Kazakhstan, Armenia, Georgia  and all other former USSR countries.

The Bulgarian headquarter coordinates global cases and our partner network in all region  of our clients’ interests.

news and articles

24/ 09/ 2019

Generic Patents
Please note!
Collaboration of companies with shared values is main goal of this project.
We will receive your message and, in two work days, we will redirect it to a company's employee whom it can be as useful as possible.
Your company has 10 opportunities per year to get acquainted with other companies. If you want to increase this amount, please contact us
Please note, that according to EBA Code of Conduct it is prohibited to perform on the EBA platform any coordinated actions, which may limit the competition between the EBA Members.
Write us in case of additional questions and suggestions.

Spelling error report

The following text will be sent to our editors: